1. Pristimerin inhibits glioma progression by targeting AGO2 and PTPN1 expression via miR-542-5p
    Zaiyu Li et al, 2019, Bioscience Reports CrossRef
  2. Anti-Cancer Effects of Pristimerin and the Mechanisms: A Critical Review
    Jia-jun Li et al, 2019, Frontiers in Pharmacology CrossRef
  3. Pristimerin in Oxidative Stress and Use in Cancer
    Ana Carolina B. da C. Rodrigues et al, 2021, Handbook of Oxidative Stress in Cancer: Therapeutic Aspects CrossRef
  4. The plant-derived triterpenoid tingenin B is a potent anticancer agent due to its cytotoxic activity on cancer stem cells of breast cancer in vitro
    Buse Cevatemre et al, 2016, Chemico-Biological Interactions CrossRef
  5. ATTEMPTS TO SYNTHESIZE A TRIMERIC DERIVATIVE OF PRISTIMERIN WITH POTENTIAL ACTIVITY AGAINST CANCER CELLS
    Josana Pereira Dos Santos et al, 2024, Revista Contemporânea CrossRef
  6. Pristimerin effectively inhibits the malignant phenotypes of uveal melanoma cells by targeting NF-κB pathway
    Biao Zhang et al, 2017, International Journal of Oncology CrossRef
  7. Pristimerin enhances the effect of cisplatin by inhibiting the miR‑23a/Akt/GSK3β signaling pathway and suppressing autophagy in lung cancer cells
    Yingbing Zhang et al, 2019, International Journal of Molecular Medicine CrossRef
  8. Pristimerin Suppresses Trophoblast Cell Epithelial–Mesenchymal Transition via miR-542-5p/EGFR Axis


    Chang Shu et al, 2020, Drug Design, Development and Therapy CrossRef
  9. Cellular and Molecular Mechanisms of Pristimerin in Cancer Therapy: Recent Advances
    Run-Ze Chen et al, 2021, Frontiers in Oncology CrossRef
  10. A promising natural product, pristimerin, results in cytotoxicity against breast cancer stem cells in vitro and xenografts in vivo through apoptosis and an incomplete autopaghy in breast cancer
    Buse Cevatemre et al, 2018, Pharmacological Research CrossRef
  11. Terpenoids, Cannabimimetic Ligands, beyond the Cannabis Plant
    Elaine C. D. Gonçalves et al, 2020, Molecules CrossRef
  12. Zhankuic Acids A, B and C from Taiwanofungus camphoratus Act as Cytotoxicity Enhancers by Regulating P-Glycoprotein in Multi-Drug Resistant Cancer Cells
    Yu-Ning Teng et al, 2019, Biomolecules CrossRef
  13. Pristimerin in Oxidative Stress and Use in Cancer
    Ana Carolina B. da C. Rodrigues et al, 2022, Handbook of Oxidative Stress in Cancer: Therapeutic Aspects CrossRef
  14. Pristimerin induces apoptosis of oral squamous cell carcinoma cells via G1 phase arrest and MAPK/Erk1/2 and Akt signaling inhibition
    Haiyan Wu et al, 2019, Oncology Letters CrossRef
  15. Pristimerin Suppressed Breast Cancer Progression via miR-542-5p/DUB3 Axis


    Shihuan Cheng et al, 2020, OncoTargets and Therapy CrossRef